ArticleOncotarget2017
MiR-34a promotes DCs development and inhibits their function on T cell activation by targeting WNT1.
Anfei Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleOncotarget2017
Anfei Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.